Day: November 28, 2019

AGILeBiotics won the Investors Forum 2019 at the Dutch Life Sciences Conference

AGILeBiotics won the Investors Forum 2019 at the Dutch Life Sciences Conference

We are proud to announce that AGILeBiotics is the winner of the Investors Forum 2019, which took place at the Dutch Life Sciences Conference in Leiden on November 28th. During the conference AGILeBiotics has introduced its drug pipeline emphasizing the pre-clinical candidate TOFRAMICIN, a novel antibiotic candidate in development against multidrug-resistant Gram-negative and Gram-positive bacterial […]